✦ LIBER ✦

P-621 Concurrent hyperfractionated radiotherapy (Hfx RT) and low-dosedaily carboplatin/paclitaxel (C/P) in patients with early stage (I/II) non-small cell lung cancer (NSCLC). Long-term results of a phase II study

✍ Scribed by Jeremic, B.; Milicic, B.; Radosavljevic-Asic, G.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preliminary results of a phase II study

✍ A. Kuten; R. Abdah-Bortnyak; L. Chetver; I. Zen Al Deen; K. Daoud; R. Nijem; S. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Induction (I) and concurrent (C) carbopl

✍ Socinski, M.A; Halle, J; Schell, M; Clark, J; Limentani, S; Mitchell, W; Fraser, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 118 KB

A phase I/II study of induction irinotec

✍ Mauer, A.M; Haraf, D.C; Rudin, C.M; Vokes, E.E 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Phase i/ii study of docetaxel (DOC) and

✍ S. Kato; M. Sakura; T. Kazumoto; H. Sakai; S. Yoneda; Y. Noguchi; K. Kobayashi; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 169 KB

A phase II study with paclitaxel and gem

✍ Ginopoulos, P.; Danikas, D.D.; Asimakopoulos, C.; Mastronikolis, N.S.; Kiriazis, 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 84 KB

P-603 Symptom response following high do

✍ Wirth, Andrew; Michael, Michael; Ball, David; MacManus, Michael; Rischin, Danny; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 176 KB